Yohei Ueda

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Endocrinology

Clinical endocrinology

PloS one

Kyoto University Graduate School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kyoto University Graduate School of Medicine Apr 01 2020

Japan

Assistant professor :: Diabetes, Endocrinology and Nutrition

Publications

Takuro Hakata, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki
High-throughput Screening for Cushing Disease: Therapeutic Potential of Thiostrepton via Cell Cycle Regulation. Endocrinology 165 (9) (2024)
Takuro Hakata, Yohei Ueda, Takafumi Yamashita, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Toshihito Fujii, Daisuke Taura, Akihiro Yasoda, Haruhiko Akiyama, Nobuya Inagaki
Neprilysin inhibition promotes skeletal growth via the CNP/NPR-B pathway. Endocrinology (2024)
Takuro Hakata, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki
High-throughput screening for Cushing disease: therapeutic potential of thiostrepton via cell cycle regulation. Endocrinology (2024)
Takuro Hakata, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki
High-throughput Screening for Cushing Disease: Therapeutic Potential of Thiostrepton via Cell Cycle Regulation. Endocrinology 165 (9) (2024)
Takuro Hakata, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Nobuya Inagaki
High-throughput Screening for Cushing Disease: Therapeutic Potential of Thiostrepton via Cell Cycle Regulation. Endocrinology 165 (9) (2024)
Takuro Hakata, Yohei Ueda, Takafumi Yamashita, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Toshihito Fujii, Daisuke Taura, Akihiro Yasoda, Haruhiko Akiyama, Nobuya Inagaki
Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway. Endocrinology 165 (7) (2024)
Takuro Hakata, Yohei Ueda, Takafumi Yamashita, Ichiro Yamauchi, Daisuke Kosugi, Taku Sugawa, Haruka Fujita, Kentaro Okamoto, Toshihito Fujii, Daisuke Taura, Akihiro Yasoda, Haruhiko Akiyama, Nobuya Inagaki
Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway. Endocrinology 165 (7) (2024)
Ichiro Yamauchi, Daisuke Taura, Takuro Hakata, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Nobuya Inagaki
Clinical features and thyroid dysfunction in adverse events involving the pituitary gland during PD-1 blockade therapy. Clinical endocrinology 94 (2) (2020)
Yohei Ueda, Keisho Hirota, Ichiro Yamauchi, Takuro Hakata, Takafumi Yamashita, Toshihito Fujii, Akihiro Yasoda, Nobuya Inagaki
Is C-type natriuretic peptide regulated by a feedback loop? A study on systemic and local autoregulatory effect. PloS one 15 (10) (2020)

Yohei Ueda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yohei Ueda